The Chromoprobe Multiprobe^® AML/MDS panel has been designed to detect up to eight different FISH probes on a single slide in a single hybridisation experiment. It can be used to determine genotype in leukaemia patients and aid in prognosis and disease management.

The panel has been designed to aid in the detection of chromosomal aberrations which occur in 30-50% and 60% of MDS and AML cases respectively, thereby providing critical information for diagnosis and prognosis. The product can also be used to monitor the course of the disease by detecting the remission, relapse, disease progression, BMT success, secondary leukaemia and Minimal Residual Disease (MRD).

The orientation of the probes on the panel is illustrated below. Click on the square to provide more information about the related probe.

The assay is supplied in a kit format of 2, 5, 10 or 20 devices and includes hybridisation solution, counterstain, template slides, a hybridisation chamber and full instructions for use. The kit even contains a unique liquid crystal display slide surface thermometer for accurate measurement of the temperature of the denaturation surface.